臨床試驗(yàn)常用的英文縮寫_第1頁(yè)
臨床試驗(yàn)常用的英文縮寫_第2頁(yè)
臨床試驗(yàn)常用的英文縮寫_第3頁(yè)
已閱讀5頁(yè),還剩7頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、創(chuàng)作:歐陽(yáng)學(xué)時(shí)間:2021.03. 03縮略語(yǔ)英文全稱中文全稱DCF data clarification form數(shù)據(jù)澄清表,用于紙質(zhì)query原始數(shù)據(jù)核對(duì)SDV source data verificationADE Adverse Drug Event藥物不良事件藥物不良反應(yīng)AE Adverse Event不良事件ADR Adverse Drug Reaction助理研究者Al Assistant InvestigatorBMI Body Mass Index體質(zhì)指數(shù)COI Coordinating InvestigatorCRA Clinical Research AssociateC

2、I Co-investigator合作研究者協(xié)調(diào)研究者臨床監(jiān)查員(臨床監(jiān)察員)CRC Clinical Research Coordinator臨床研究協(xié)調(diào)者CRF Case Report Form病歷報(bào)告表CRO Contract Research Organization合同研究組織CSA Clinical Study Application臨味研究申請(qǐng)CTA Clinical Trial Application臨床試驗(yàn)申請(qǐng)CTX Clinical Trial Exemption臨床試驗(yàn)免責(zé)CTP Clinical Trial Protocol臨床試驗(yàn)方案CTR Clinical Tria

3、l Report臨床試驗(yàn)報(bào)告DSMB Data Safety and monitoring Board 數(shù)據(jù)安全及監(jiān)控委員會(huì)EDC Electronic Data Capture電子數(shù)據(jù)采集系統(tǒng)EDP Electronic Data Processing電子數(shù)據(jù)處理系統(tǒng)FDA Food and Drug Administration美國(guó)食品與藥品管理局FR Final ReportGCP Good Clinical Practice 理規(guī)范GLP Good Laboratory Practice 管理規(guī)范GMP Good Manufacturing Practice 規(guī)范總結(jié)報(bào)告藥物臨床試驗(yàn)質(zhì)

4、量管藥物非臨床試驗(yàn)質(zhì)量藥品生產(chǎn)質(zhì)量管理IB Investigator's BrochureIC Informed Consent研究者手冊(cè)知情同意ICF Informed Consent Form知情同意書ICH International Conference on Harmonization 國(guó) 際協(xié)調(diào) 會(huì)議IDM Independent Data Monitoring 獨(dú)立數(shù)據(jù)監(jiān)察IDMC Independent Data Monitoring Committee 獨(dú)立數(shù)據(jù) 監(jiān)委員IEC Independent Ethics Committee獨(dú)立倫理委員會(huì)IND Investi

5、gational New Drug新藥臨床研究IRB Institutional Review Board機(jī)構(gòu)審查委員會(huì)IVD In Vitro Diagnostic體外診斷IVRS Interactive Voice Response System 互動(dòng)語(yǔ)音應(yīng)答系 統(tǒng)MAMarketing Approval/Authorization 上市許可證MCA Medicines Control Agency英國(guó)藥品監(jiān)替局MHW Ministry of Health and Welfare 日本衛(wèi)生福利 部NDANew Drug Application新藥申請(qǐng)NEC New Drug Entity新

6、化學(xué)實(shí)體NIH National Institutes of Health國(guó)家衛(wèi)生研究所(美國(guó))主要研究者PI Principal InvestigatorPL Product License嚴(yán)品許可證PMA Pre-market Approval (Application)上市前許可(申 請(qǐng))PSI Statisticians in the Pharmaceutical Industry 制藥業(yè)統(tǒng) 計(jì)學(xué)家協(xié)會(huì)QAQuality Assurance質(zhì)量保證QCQuality Control質(zhì)量控制RARegulatory Authorities監(jiān)督管理部門SASite Assessment現(xiàn)場(chǎng)

7、評(píng)估SAESerious Adverse Event嚴(yán)瑩不良事件SAPStatistical Analysis Plan統(tǒng)計(jì)分析計(jì)劃SARSerious Adverse Reaction嚴(yán)遠(yuǎn)不良反應(yīng)SDSource Data/Document原始數(shù)據(jù)/文件SDSubject Diary受試者日記SFDA State Food and Drug Administration 國(guó)家食品藥品監(jiān)督管理局SDV Source Data Verification原始數(shù)據(jù)核準(zhǔn)SEL Subject Enrollment Log受試者入選表SI Sub-investigator助理研究者SI Sponsor-

8、Investigator申辦研究者SIC Subject Identification Code受試者識(shí)別代碼SOP Standard Operating Procedure 標(biāo)準(zhǔn)操作規(guī)程SPL Study Personnel List研究人員名單SSL Subject Screening Log受試者篩選表T&R Test and Reference Product受試和參比試劑UAE Unexpected Adverse Event預(yù)料外不良事件WHO World Health Organization世界衛(wèi)生組織WHO-ICDRA WHO International Confer

9、ence of Drug Regulatory Authorities WHO國(guó)際藥品管理當(dāng)局會(huì)議Active Control陽(yáng)性對(duì)照、活性對(duì)照Audit稽查Audit Report稽查報(bào)吿Auditor稽查員Blank Control空白對(duì)照Blinding/masking盲法/設(shè)盲Case History病歷Clinical study臨床研究Clinical Trial臨床試驗(yàn)Clinical Trial Report臨床試驗(yàn)報(bào)告Compliance依從性Coordinating Committee協(xié)調(diào)委員會(huì)Cross-over Study交叉研究Double Blinding雙盲End

10、point Criteria/measurement 終點(diǎn)指標(biāo)研究者監(jiān)查員(監(jiān)察員)監(jiān)查(監(jiān)察)監(jiān)查計(jì)劃(監(jiān)察計(jì)劃)監(jiān)查報(bào)吿(監(jiān)察報(bào)告)多中丿試驗(yàn)WE臨床研究原始醫(yī)療記錄結(jié)果評(píng)價(jià)病人檔案Essential DocumentationExclusion CriteriaInclusion CriteriaInformation GatheringInitial MeetingInspectionInstitution InspectionInvestigational ProductInvestigatorMonitorMonitoringMonitoring PlanMonitoring Re

11、portMulti-center TrialNon-clinical StudyOriginal Medical RecordOutcome AssessmentPatient FilePatient HistoryPlaceboPlacebo ControlPreclinical Study必需文件須E除標(biāo)準(zhǔn)入選表準(zhǔn)信息收集啟動(dòng)會(huì)議檢察/視察機(jī)構(gòu)檢察試驗(yàn)藥物病歷安慰劑安慰劑對(duì)照臨床前研究ProtocolProtocol AmendmentsRandomizationReference ProductSample SizeSeriousnessSeveritySingle BlindingSponsorStudy AuditSubjectSubject EnrollmentSubject Enrollment LogSubject Identification Code ListSubject RecruitmentStudy SiteSubject Screening LogSystem AuditTest ProductTrial Initial MeetingTrial Mast

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論